Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescence-guided Resection of Malignant Gliomas with 5-ALA
NCT00241670Phase 3Completed
- Sponsor
- medac GmbH
- Start
- Oct 1999
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in malignant glioma, sponsored by medac GmbH. Started Oct 1999; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00241670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241670.